Delly Behen

Delly Behen

Hoofd Administratief Officier bij ATOSSA THERAPEUTICS, INC.

Consumer Services
Health Technology

Oorsprong van het eerstegraads netwerk van Delly Behen

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 26

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Delly Behen via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
CORCEPT THERAPEUTICS INCORPORATED Pharmaceuticals: Major

Arezoo Mirad

Chief Tech/Sci/R&D Officer

Hospital/Nursing Management

H. Remmel

Director/Board Member

Nyenrode Business Universiteit College/University

Pieter van der Poel

Undergraduate Degree

Michigan State University College/University

Shu-Chih Chen

Doctorate Degree

University of Virginia College/University

Jonathan Finn

Undergraduate Degree

Stanford University College/University

Richard Graydon

Doctorate Degree

College/University

Gerald Engley

Janet Rose Rea

Doctorate Degree

Graduate Degree

Miscellaneous Commercial Services

Kyle Guse

Corporate Officer/Principal

Miscellaneous Commercial Services

Kyle Guse

Corporate Officer/Principal

Miscellaneous Commercial Services

H. Remmel

Corporate Officer/Principal

Miscellaneous Commercial Services

Kyle Guse

Corporate Officer/Principal

Medical Specialties

Christopher S. Destro

Sales & Marketing

The California State University College/University

John Barnhart

Devon Payne

Undergraduate Degree

Undergraduate Degree

California State University-Sacramento College/University

Kyle Guse

Masters Business Admin

Gonzaga University College/University

Heather Rees

Undergraduate Degree

Iona College College/University

Peter J. Carbonaro

Masters Business Admin

The Johns Hopkins University College/University

Ben R. Chen

Graduate Degree

College/University

Richard Graydon

Undergraduate Degree

Franklin & Marshall College College/University

Eric van Zanten

Undergraduate Degree

College/University

Christopher S. Destro

Undergraduate Degree

Purdue University College/University

Ben R. Chen

Undergraduate Degree

Siena College College/University

Peter J. Carbonaro

Undergraduate Degree

Biotechnology

Steven Quay

Stephen Galli

Corporate Officer/Principal

President

FORMOSA LABORATORIES, INC. Pharmaceuticals: Major

Ben R. Chen

Corporate Officer/Principal

Association of Pathology Chairs

Stephen Galli

President

Stanford University School of Medicine College/University

Stephen Galli

Corporate Officer/Principal

Harvard Medical School College/University

Stephen Galli

Doctorate Degree

Harvard College College/University

Stephen Galli

Undergraduate Degree

National Yang Ming University College/University

Shu-Chih Chen

Corporate Officer/Principal

The Santa Clara University School of Law College/University

Kyle Guse

Graduate Degree

Miscellaneous Commercial Services

H. Remmel

Director/Board Member

Biotechnology

H. Remmel

Director/Board Member

WUXI APPTEC CO., LTD. Pharmaceuticals: Major

Ben R. Chen

General Counsel

Investment Managers

Jonathan Finn

Chief Investment Officer

The University of Colorado College/University

Arezoo Mirad

Doctorate Degree

Pharmaceuticals: Major

Richard Graydon

Chief Tech/Sci/R&D Officer

FARON PHARMACEUTICALS OY Pharmaceuticals: Major

Eric van Zanten

Investor Relations Contact

UROGEN PHARMA LTD. Biotechnology

Eric van Zanten

Public Communications Contact

Biotechnology

Jonathan Finn

Private Equity Investor

Information Technology Services

Jonathan Finn

Private Equity Investor

Investment Managers

Jonathan Finn

Chief Investment Officer

Electric Utilities

Jonathan Finn

Private Equity Investor

Statistieken

Internationaal

Verenigde Staten 37
Taiwan 3
Zweden 3
Nederland 2
Ierland 2

Sectoraal

Consumer Services 22
Health Technology 12
Commercial Services 8
Finance 3
Health Services 2

Operationeel

Corporate Officer/Principal 30
Director of Finance/CFO 25
Undergraduate Degree 24
Director/Board Member 22
Chief Tech/Sci/R&D Officer 12
  1. Beurs
  2. Insiders
  3. Delly Behen
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU